Abstract
Background
The return on investment (ROI) of mental health care is a critical metric in an era of cost-conscious healthcare decision-making. However, selective reporting of positive study results may inflate ROI estimates.
Objective
To quantify the mean and variation in employer-level ROI outcomes for a comprehensive behavioral health benefit program.
Methods
Data were obtained from 19 employer-specific studies conducted between May 2023 and December 2024. Sources included medical claims data spanning 12 months pre- and post-program launch, and program billing records of clinical and nonclinical costs. Studies were included if they were conducted by a single behavioral health benefit where the full sample of studies was known. The population included 19 US employers where employees and dependents received up to 12 free psychotherapy or medication management sessions. All studies used the same inclusion and exclusion criteria, retrospective matched cohort design, and difference-in-differences analysis. Data were abstracted following PRISMA guidelines. ROI was estimated using a difference-in-differences model to control for baseline medical spending and pooled using inverse variance weighting with a random effects structure. The primary outcome was the ROI multiple, defined as the ratio of gross per-member-per-month savings to total program spending.
Results
The meta-analysis included 42 148 participants (14 645 program users and 27 503 matched controls) across a range of employer sizes and industries. The pooled ROI multiple was 2.3 (95% CI, 1.9-2.8), corresponding to net savings of $159 per member per month (95% CI, $111-$207). Significant heterogeneity was observed (I² = 67.8%; t² = 0.646;
P
Conclusion
This meta-analysis, the largest of its kind, demonstrates that a centralized behavioral health benefit can consistently generate net savings across varied employer settings. These findings provide robust evidence to support the adoption of comprehensive mental health programs as an effective strategy for reducing overall medical spending in employer-sponsored health plans.